/PTHL

PTHL Stock - Pheton Holdings Ltd Class A Ordinary Shares

Q: What is the analyst price target for PTHL?

Analyst price target information is not currently available for PTHL.

Q: What is PTHL's market cap?

Market capitalization information is not currently available for PTHL.

Healthcare|Medical - Devices|NASDAQ

$0.50-2.63%

$0.01 (-2.63%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

SELL

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.55

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PTHL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta5.04

52W High$32.00

52W Low$0.47

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	$448,196	$628,591	$679,777	$702,776
Gross Profit	$381,155	$470,828	$558,150	$590,743
Gross Margin	85.0%	74.9%	82.1%	84.1%
Operating Income	$-770,000	$-306,680	$27,521	$138,086
Net Income	$-661,000	$-241,217	$83,980	$192,462
Net Margin	-147.5%	-38.4%	12.4%	27.4%
EPS	$-0.05	$-0.02	$0.01	$0.01

Company Overview

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.

Visit Website

Frequently Asked Questions about PTHL

What is PTHL's current stock price?

Pheton Holdings Ltd Class A Ordinary Shares (PTHL) is currently trading at $0.50 per share. The stock has moved -2.63% today.

What is the analyst price target for PTHL?

No analyst price targets are currently available for this stock.

What sector is Pheton Holdings Ltd Class A Ordinary Shares in?

Pheton Holdings Ltd Class A Ordinary Shares operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is PTHL's market cap?

Pheton Holdings Ltd Class A Ordinary Shares has a market capitalization of $0.01 billion, making it a small-cap company.

Does PTHL pay dividends?

No, Pheton Holdings Ltd Class A Ordinary Shares does not currently pay a dividend to shareholders.